Cargando…

Immunity, Inflammation and Heart Failure: Their Role on Cardiac Function and Iron Status

Aims: Heart failure is a clinical syndrome characterized by subclinical systemic inflammation and immune system activation associated with iron deficiency. No data exist on the various activations of immune-mediated mechanisms of inflammation in heart failure patients with reduced/preserved ejection...

Descripción completa

Detalles Bibliográficos
Autores principales: Perticone, Maria, Zito, Roberta, Miceli, Sofia, Pinto, Angelina, Suraci, Edoardo, Greco, Marta, Gigliotti, Simona, Hribal, Marta Letizia, Corrao, Salvatore, Sesti, Giorgio, Perticone, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779858/
https://www.ncbi.nlm.nih.gov/pubmed/31632400
http://dx.doi.org/10.3389/fimmu.2019.02315
_version_ 1783456988565340160
author Perticone, Maria
Zito, Roberta
Miceli, Sofia
Pinto, Angelina
Suraci, Edoardo
Greco, Marta
Gigliotti, Simona
Hribal, Marta Letizia
Corrao, Salvatore
Sesti, Giorgio
Perticone, Francesco
author_facet Perticone, Maria
Zito, Roberta
Miceli, Sofia
Pinto, Angelina
Suraci, Edoardo
Greco, Marta
Gigliotti, Simona
Hribal, Marta Letizia
Corrao, Salvatore
Sesti, Giorgio
Perticone, Francesco
author_sort Perticone, Maria
collection PubMed
description Aims: Heart failure is a clinical syndrome characterized by subclinical systemic inflammation and immune system activation associated with iron deficiency. No data exist on the various activations of immune-mediated mechanisms of inflammation in heart failure patients with reduced/preserved ejection fraction. We aimed to (1) investigate possible differences in inflammatory parameters and oxidative stress, and (2) detect a different iron status between groups. Materials and Methods: We enrolled 50 consecutive Caucasian outpatients with heart failure. All patients underwent echocardiographic measurements, laboratory determinations, evaluation of iron status and Toll-like receptors, and NF-κB expression in peripheral blood mononuclear cells, as well as pro-inflammatory cytokines. All statistical calculations were made using SPSS for Mac version 21.0. Results: Patients with reduced ejection fraction showed significantly lower hemoglobin levels (12.3 ± 1.4 vs. 13.6 ± 1.4 g/dl), serum iron (61.4 ± 18.3 vs. 93.7 ± 33.7 mcg/dl), transferrin iron binding capacity (20.7 ± 8.4 vs. 31.1 ± 15.6 %), and e-GFR values (78.1 ± 36.1 vs. 118.1 ± 33.9 ml/min/1.73 m(2)) in comparison to patients with preserved ejection fraction, while unsaturated iron binding capacity (272.6 ± 74.9 vs. 221.7 ± 61.4 mcg/dl), hepcidin (4.61 ± 0.89 vs. 3.28 ± 0.69 ng/ml), and creatinine (1.34 ± 0.55 vs. 1.03 ± 0.25 mg/dl) were significantly higher in the same group. When considering inflammatory parameters, patients with reduced ejection fraction showed significantly higher expression of both Toll-like receptors-2 (1.90 ± 0.97 vs. 1.25 ± 0.76 MFI) and Toll-like receptors-4 (4.54 ± 1.32 vs. 3.38 ± 1.62 MFI), respectively, as well as a significantly higher activity of NF-κB (2.67 ± 0.60 vs. 1.07 ± 0.30). Furthermore, pro-inflammatory cytokines, interleukin-1, and interleukin-6, was significantly higher in patients with reduced ejection fraction, while the protective cytokine interleukin-10 was significantly lower in the same group. Correlational analyses demonstrated a significant and inverse relationship between left ventricular function and inflammatory parameters in patients with reduced ejection fraction, as well as a direct correlation between ferritin and inflammatory parameters. Conclusions: Our data demonstrate a different immune-mediated inflammatory burden in heart failure patients with reduced or preserved ejection fraction, as well as significant differences in iron status. These data contribute to further elucidate pathophysiologic mechanisms leading to cardiac dysfunction.
format Online
Article
Text
id pubmed-6779858
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-67798582019-10-18 Immunity, Inflammation and Heart Failure: Their Role on Cardiac Function and Iron Status Perticone, Maria Zito, Roberta Miceli, Sofia Pinto, Angelina Suraci, Edoardo Greco, Marta Gigliotti, Simona Hribal, Marta Letizia Corrao, Salvatore Sesti, Giorgio Perticone, Francesco Front Immunol Immunology Aims: Heart failure is a clinical syndrome characterized by subclinical systemic inflammation and immune system activation associated with iron deficiency. No data exist on the various activations of immune-mediated mechanisms of inflammation in heart failure patients with reduced/preserved ejection fraction. We aimed to (1) investigate possible differences in inflammatory parameters and oxidative stress, and (2) detect a different iron status between groups. Materials and Methods: We enrolled 50 consecutive Caucasian outpatients with heart failure. All patients underwent echocardiographic measurements, laboratory determinations, evaluation of iron status and Toll-like receptors, and NF-κB expression in peripheral blood mononuclear cells, as well as pro-inflammatory cytokines. All statistical calculations were made using SPSS for Mac version 21.0. Results: Patients with reduced ejection fraction showed significantly lower hemoglobin levels (12.3 ± 1.4 vs. 13.6 ± 1.4 g/dl), serum iron (61.4 ± 18.3 vs. 93.7 ± 33.7 mcg/dl), transferrin iron binding capacity (20.7 ± 8.4 vs. 31.1 ± 15.6 %), and e-GFR values (78.1 ± 36.1 vs. 118.1 ± 33.9 ml/min/1.73 m(2)) in comparison to patients with preserved ejection fraction, while unsaturated iron binding capacity (272.6 ± 74.9 vs. 221.7 ± 61.4 mcg/dl), hepcidin (4.61 ± 0.89 vs. 3.28 ± 0.69 ng/ml), and creatinine (1.34 ± 0.55 vs. 1.03 ± 0.25 mg/dl) were significantly higher in the same group. When considering inflammatory parameters, patients with reduced ejection fraction showed significantly higher expression of both Toll-like receptors-2 (1.90 ± 0.97 vs. 1.25 ± 0.76 MFI) and Toll-like receptors-4 (4.54 ± 1.32 vs. 3.38 ± 1.62 MFI), respectively, as well as a significantly higher activity of NF-κB (2.67 ± 0.60 vs. 1.07 ± 0.30). Furthermore, pro-inflammatory cytokines, interleukin-1, and interleukin-6, was significantly higher in patients with reduced ejection fraction, while the protective cytokine interleukin-10 was significantly lower in the same group. Correlational analyses demonstrated a significant and inverse relationship between left ventricular function and inflammatory parameters in patients with reduced ejection fraction, as well as a direct correlation between ferritin and inflammatory parameters. Conclusions: Our data demonstrate a different immune-mediated inflammatory burden in heart failure patients with reduced or preserved ejection fraction, as well as significant differences in iron status. These data contribute to further elucidate pathophysiologic mechanisms leading to cardiac dysfunction. Frontiers Media S.A. 2019-10-01 /pmc/articles/PMC6779858/ /pubmed/31632400 http://dx.doi.org/10.3389/fimmu.2019.02315 Text en Copyright © 2019 Perticone, Zito, Miceli, Pinto, Suraci, Greco, Gigliotti, Hribal, Corrao, Sesti and Perticone. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Perticone, Maria
Zito, Roberta
Miceli, Sofia
Pinto, Angelina
Suraci, Edoardo
Greco, Marta
Gigliotti, Simona
Hribal, Marta Letizia
Corrao, Salvatore
Sesti, Giorgio
Perticone, Francesco
Immunity, Inflammation and Heart Failure: Their Role on Cardiac Function and Iron Status
title Immunity, Inflammation and Heart Failure: Their Role on Cardiac Function and Iron Status
title_full Immunity, Inflammation and Heart Failure: Their Role on Cardiac Function and Iron Status
title_fullStr Immunity, Inflammation and Heart Failure: Their Role on Cardiac Function and Iron Status
title_full_unstemmed Immunity, Inflammation and Heart Failure: Their Role on Cardiac Function and Iron Status
title_short Immunity, Inflammation and Heart Failure: Their Role on Cardiac Function and Iron Status
title_sort immunity, inflammation and heart failure: their role on cardiac function and iron status
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779858/
https://www.ncbi.nlm.nih.gov/pubmed/31632400
http://dx.doi.org/10.3389/fimmu.2019.02315
work_keys_str_mv AT perticonemaria immunityinflammationandheartfailuretheirroleoncardiacfunctionandironstatus
AT zitoroberta immunityinflammationandheartfailuretheirroleoncardiacfunctionandironstatus
AT micelisofia immunityinflammationandheartfailuretheirroleoncardiacfunctionandironstatus
AT pintoangelina immunityinflammationandheartfailuretheirroleoncardiacfunctionandironstatus
AT suraciedoardo immunityinflammationandheartfailuretheirroleoncardiacfunctionandironstatus
AT grecomarta immunityinflammationandheartfailuretheirroleoncardiacfunctionandironstatus
AT gigliottisimona immunityinflammationandheartfailuretheirroleoncardiacfunctionandironstatus
AT hribalmartaletizia immunityinflammationandheartfailuretheirroleoncardiacfunctionandironstatus
AT corraosalvatore immunityinflammationandheartfailuretheirroleoncardiacfunctionandironstatus
AT sestigiorgio immunityinflammationandheartfailuretheirroleoncardiacfunctionandironstatus
AT perticonefrancesco immunityinflammationandheartfailuretheirroleoncardiacfunctionandironstatus